166 related articles for article (PubMed ID: 38866365)
41. Efficacy of a herbal mouthwash for management of periodontitis and radiation-induced mucositis - A consolidated report of two randomized controlled clinical trials.
Ambili R; Ramadas K; Nair LM; Raj D; Nazeer F; George PS; Rejnish Kumar R; Radhakrishna Pillai M
J Ayurveda Integr Med; 2023; 14(6):100791. PubMed ID: 37897968
[TBL] [Abstract][Full Text] [Related]
42. Effects of a Plantago ovata-based herbal compound in prevention and treatment of oral mucositis in patients with breast cancer receiving chemotherapy: A double-blind, randomized, controlled crossover trial.
Hasheminasab FS; Hashemi SM; Dehghan A; Sharififar F; Setayesh M; Sasanpour P; Tasbandi M; Raeiszadeh M
J Integr Med; 2020 May; 18(3):214-221. PubMed ID: 32268991
[TBL] [Abstract][Full Text] [Related]
43. Oral Mucositis Due to High-Dose Chemotherapy and/or Head and Neck Radiation Therapy.
Lalla RV; Brennan MT; Gordon SM; Sonis ST; Rosenthal DI; Keefe DM
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425601
[TBL] [Abstract][Full Text] [Related]
44. Mucositis: biology and management.
Treister N; Sonis S
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):123-9. PubMed ID: 17413415
[TBL] [Abstract][Full Text] [Related]
45. Effect of basic fibroblast growth factor on radiation-induced oral mucositis in male Syrian hamsters.
Sumikawa S; Watanabe S; Tanaka M; Tanaka A; Araki H
Int J Radiat Biol; 2017 Dec; 93(12):1343-1349. PubMed ID: 29034752
[TBL] [Abstract][Full Text] [Related]
46. A prospective comparison of common toxicity criteria adverse events Version 3 and 4 in assessing oral mucositis for oral and oropharyngeal carcinoma.
Hickman M; Meade SJ; Fong C; Sanghera P; Good J; Hartley A
Tech Innov Patient Support Radiat Oncol; 2017 Mar; 1():18-21. PubMed ID: 32095539
[TBL] [Abstract][Full Text] [Related]
47. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy.
Peterson DE; Cariello A
Semin Oncol; 2004 Jun; 31(3 Suppl 8):35-44. PubMed ID: 15181607
[TBL] [Abstract][Full Text] [Related]
48. Macroscopic and microscopic effects of GaAIAs diode laser and dexamethasone therapies on oral mucositis induced by fluorouracil in rats.
Lara RN; da Guerra EN; de Melo NS
Oral Health Prev Dent; 2007; 5(1):63-71. PubMed ID: 17366763
[TBL] [Abstract][Full Text] [Related]
49. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia.
Radvansky LJ; Pace MB; Siddiqui A
Am J Health Syst Pharm; 2013 Jun; 70(12):1025-32. PubMed ID: 23719879
[TBL] [Abstract][Full Text] [Related]
50. Current trends in the management of oral mucositis related to cancer treatment.
Biswal BM
Malays J Med Sci; 2008 Jul; 15(3):4-13. PubMed ID: 22570584
[TBL] [Abstract][Full Text] [Related]
51. Low level laser therapy in oral mucositis: a pilot study.
Cauwels RG; Martens LC
Eur Arch Paediatr Dent; 2011 Apr; 12(2):118-23. PubMed ID: 21473845
[TBL] [Abstract][Full Text] [Related]
52. Chemotherapy-induced oral mucositis management: A retrospective analysis of MuGard, Caphosol, and standard supportive care measures.
Murdock JL; Reeves DJ
J Oncol Pharm Pract; 2020 Apr; 26(3):521-528. PubMed ID: 31142234
[TBL] [Abstract][Full Text] [Related]
53. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome.
Beckers AB; Weerts ZZRM; Helyes Z; Masclee AAM; Keszthelyi D
Aliment Pharmacol Ther; 2017 Nov; 46(10):938-952. PubMed ID: 28884838
[TBL] [Abstract][Full Text] [Related]
54. N-succinyl chitosan as buccal penetration enhancer for delivery of herbal agents in treatment of oral mucositis.
Dhawan N; Kumar K; Kalia AN; Arora S
Curr Drug Deliv; 2014; 11(3):415-25. PubMed ID: 24295296
[TBL] [Abstract][Full Text] [Related]
55. Treatment of symptomatic oral mucositis with sodium hyaluronate and synthetic amino acid precursors of collagen in patients undergoing haematopoietic stem cell transplantation.
Ruggiero T; Pol R; Camisassa D; Simiele S; Giaccone L; Carossa S
J Biol Regul Homeost Agents; 2018; 32(3):737-743. PubMed ID: 29921408
[TBL] [Abstract][Full Text] [Related]
56. Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study.
Schaller AKCS; Peterson A; Bäckryd E
Scand J Pain; 2021 Apr; 21(2):256-265. PubMed ID: 34387952
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of topical external medicine for 5-fluorouracil-induced oral mucositis in hamsters.
Mitsuhashi H; Suemaru K; Li B; Cui R; Araki H
Eur J Pharmacol; 2006 Dec; 551(1-3):152-5. PubMed ID: 17046745
[TBL] [Abstract][Full Text] [Related]
58. Interventions for the Prevention of Oral Mucositis in Patients Receiving Cancer Treatment: Evidence from Randomised Controlled Trials.
Colella G; Boschetti CE; Vitagliano R; Colella C; Jiao L; King-Smith N; Li C; Nuoh Lau Y; Lai Z; Mohammed AI; Cirillo N
Curr Oncol; 2023 Jan; 30(1):967-980. PubMed ID: 36661723
[TBL] [Abstract][Full Text] [Related]
59. Influence of the microbiome on radiotherapy-induced oral mucositis and its management: A comprehensive review.
Fernández Forné Á; García Anaya MJ; Segado Guillot SJ; Plaza Andrade I; de la Peña Fernández L; Lorca Ocón MJ; Lupiáñez Pérez Y; Queipo-Ortuño MI; Gómez-Millán J
Oral Oncol; 2023 Sep; 144():106488. PubMed ID: 37399707
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of bioadhesives in the management of oral mucositis in patients undergoing radio-chemotherapy for treatment of head and neck cancer-a systematic review and meta-analysis.
Jayapriya T; Keluskar V; Lagali-Jirge V; Sridhar M
Support Care Cancer; 2023 Jul; 31(8):470. PubMed ID: 37458879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
